PLENDIL

This brand name is authorized in Austria, Australia, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Hong Kong, Ireland, Italy, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug PLENDIL contains one active pharmaceutical ingredient (API):

1	Felodipine UNII OL961R6O2C - FELODIPINE
	Felodipine is a vascular selective calcium antagonist, which lowers arterial blood pressure by decreasing systemic vascular resistance. Felodipine is effective in all grades of hypertension.
	Read more about Felodipine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PLENDIL Prolonged-release tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C08CA02	Felodipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2361G, 2366M, 2367N
CA	Health Products and Food Branch	00851779, 00851787, 02057778
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28921-07-09, 28944-07-09
EE	Ravimiamet	1019696, 1019708, 1028135, 1072482, 1072516, 1072527, 1732698, 1732700, 1732711, 1733790, 1733802, 1733813, 1733824, 1733835, 1733846, 1733914, 1733925, 1733936, 1733947, 1733992, 1734005, 1734016, 1734027, 1734038, 1734049
ES	Centro de información online de medicamentos de la AEMPS	59269
FI	Lääkealan turvallisuus- ja kehittämiskeskus	093062, 471441, 471466
GB	Medicines & Healthcare Products Regulatory Agency	13551, 13552, 139461, 147217, 175887, 180654, 354774
HK	Department of Health Drug Office	32695, 32696, 37191
IE	Health Products Regulatory Authority	40030, 40031, 40035, 40041
IT	Agenzia del Farmaco	028162030, 028162042
LT	Valstybinė vaistų kontrolės tarnyba	1003616, 1003731, 1019656, 1081017, 1081018, 1081019, 1081020, 1081021, 1081022, 1081023, 1081024, 1081025, 1081026, 1081027, 1081028, 1081029, 1081030, 1081031, 1081032, 1081033, 1081034, 1081035, 1081036, 1081037, 1081038, 1081039, 1081040, 1081041, 1081042, 1081043, 1081044, 1081045
MT	Medicines Authority	MA046/00201
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	224M89
NG	Registered Drug Product Database	04-2256, 04-2257
NL	Z-Index G-Standaard, PRK	35726
NZ	Medicines and Medical Devices Safety Authority	4046, 4051, 4052
PL	Rejestru Produktów Leczniczych	100053594, 100053602
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W03102002, W03103001, W03104001
SG	Health Sciences Authority	07738P, 08768P, 08781P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699786030206, 8699786031340
ZA	Health Products Regulatory Authority	Y/7.1/294, Y/7.1/295